Keep up with what’s happening at Idera Pharmaceuticals.
- 3 Patients with PD-1 Refractory Cutaneous Melanoma are Responders Including One Complete… Read more
Presentation to be made at Cold Springs Harbor Laboratory Conference on Regulatory &… Read more
CAMBRIDGE, Mass. and EXTON, Pa., Aug. 12, 2016 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc.… Read more